NGM Biopharmaceuticals Inc (NGM)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO, CA 94080

NGM is a biopharmaceutical company focused on discovering and developing novel therapeutics based on scientific understanding of key biological pathways underlying liver and metabolic diseases, retinal diseases and cancer. The Company leverages its biology-centric drug discovery approach to uncover novel mechanisms of action and generate proprietary insights that enable it to move rapidly into proof-of-concept studies and deliver potential first-in-class medicines to patients. NGM aspires to operate one of the most productive research and development engines in the biopharmaceutical industry.

Data as of 2021-07-19 09:53:17 -0400
Market Cap1.61 Billion Shares Outstanding77.018 Million Avg 30-day Volume392.041 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-0.2 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.47476 52-week High/Low32.12 / 14.9 Next Earnings Date2021-08-12 Price to Cash FLow (P/CF) -54.9138
Data provided by IEX Cloud
View SEC Filings from NGM instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 7 7 0.0% 3 (0.18%) 3 (0.17%) 0.0%
Funds Holding: 107 89 20.22% 34 (2.0%) 26 (1.51%) 30.77%
13F shares: 43.025 Million 37.106 Million 15.95% 15.195 Million 10.507 Million 44.62%
% Ownership 56.1009 53.203 5.45% 19.8127 15.0647 31.52%
New Positions: 27 20 35.0% 11 6 83.33%
Increased Positions 39 26 50.0% 13 7 85.71%
Closed Positions 8 12 -33.33% 3 5 -40.0%
Reduced Positions 18 30 -40.0% 5 10 -50.0%
Total Calls 48.3 Thousand 21.5 Thousand 124.65% 22.2 Thousand 10 Thousand 122.0%
Total Puts 148
PUT/CALL Ratio 0.0 0.0 0.0 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding NGM (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NGM BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

69.4 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LESCHLY MARK

  • Director
19,619 2021-06-08 1

HOOPER SUZANNE SAWOCHKA

  • Director
19,619 2021-06-08 1

GOEDDEL DAVID V

  • Director
  • 10% Owner
19,619 2021-06-08 1

GUYER SHELLY D

  • Director
19,619 2021-06-08 1

HO CAROLE

  • Director
19,619 2021-06-08 1

PERLMUTTER ROGER M

  • Director
46,238 2021-06-08 2

CHEN JIN-LONG CHIEF SCIENTIFIC OFFICER

  • Officer
  • Director
989,449 2021-06-03 12

WOODHOUSE DAVID J CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
450,000 2021-03-17 1

RIEFLIN WILLIAM JL EXECUTIVE CHAIRMAN

  • Officer
  • Director
80,000 2021-03-17 1

LIEU HSIAO D SVP, CHIEF MEDICAL OFFICER

  • Officer
100,000 2021-03-17 1

NOLAN MANGINI SIOBHAN CHIEF FINANCIAL OFFICER

  • Officer
50,000 2021-03-17 2

PIERCE VALERIE L SVP, GC & CCO

  • Officer
100,000 2021-03-17 2

COLUMN GROUP L P

COLUMN GROUP GP, LP

COLUMN GROUP II, LP

COLUMN GROUP II GP, LP

COLUMN GROUP MANAGEMENT LP

PONOI CAPITAL, LP

PONOI MANAGEMENT, LLC

PONOI CAPITAL II, LP

PONOI II MANAGEMENT, LLC

KUTZKEY TIM

  • Director
  • 10% Owner
  • GENERAL PARTNER GENERAL PARTNER GENERAL PARTNERMANAGING PARTNER
18,242,932 2020-09-01 12

COLUMN GROUP L P

COLUMN GROUP III, LP

COLUMN GROUP III-A, LP

COLUMN GROUP III GP, LP

SVENNILSON PETER

GOEDDEL DAVID V

  • Director
  • 10% Owner
  • GENERAL PARTNERMANAGING PARTNERMANAGING PARTNER
18,242,932 2020-09-01 12

TICHENOR MCHENRY T

  • Director
0 2020-05-20 0

SCHNELL DAVID

  • Director
0 2020-05-20 0

SVENNILSON PETER

  • Director
  • 10% Owner
17,726,978 2020-04-08 0

COLUMN GROUP L P

COLUMN GROUP III, LP

COLUMN GROUP III-A, LP

COLUMN GROUP III GP, LP

  • 10% Owner
  • GENERAL PARTNER
17,721,978 2020-04-08 0

TROMBLEY AETNA WUN PRESIDENT & COO

  • Officer
0 2020-02-04 0

COLUMN GROUP III, LP

COLUMN GROUP III-A, LP

COLUMN GROUP III GP, LP

  • 10% Owner
  • GENERAL PARTNER
53,172 2019-10-09 0

COLUMN GROUP L P

COLUMN GROUP II, LP

COLUMN GROUP GP, LP

COLUMN GROUP II GP, LP

COLUMN GROUP MANAGEMENT LP

COLUMN GROUP III, LP

COLUMN GROUP III-A, LP

COLUMN GROUP III GP, LP

PONOI MANAGEMENT, LLC

PONOI CAPITAL, LP

  • Director
  • 10% Owner
  • GENERAL PARTNER GENERAL PARTNERGENERAL PARTNER
17,912,171 2019-05-15 12

COLUMN GROUP L P

PONOI CAPITAL II, LP

PONOI II MANAGEMENT, LLC

SVENNILSON PETER

KUTZKEY TIM

GOEDDEL DAVID V

  • Director
  • 10% Owner
  • GENERAL PARTNERMANAGING PARTNERMANAGING PARTNERMANAGING PARTNER
17,912,171 2019-05-15 0

MERCK & CO., INC.

MERCK SHARP & DOHME CORP.

  • 10% Owner
12,955,016 2019-04-08 0

PONOI CAPITAL, LP

PONOI MANAGEMENT, LLC

PONOI CAPITAL II, LP

PONOI II MANAGEMENT, LLC

KUTZKEY TIM

  • 10% Owner
  • GENERAL PARTNER GENERAL PARTNERMANAGING PARTNER
1,890,000 2019-04-08 0

COLUMN GROUP L P

COLUMN GROUP II, LP

COLUMN GROUP GP, LP

COLUMN GROUP MANAGEMENT LP

COLUMN GROUP II GP, LP

  • 10% Owner
  • GENERAL PARTNER GENERAL PARTNER
475,957 2019-04-03 12

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

HO CAROLE - Director

2021-06-10 17:39:39 -0400 2021-06-08 A 19,619 a 19,619 direct

PERLMUTTER ROGER M - Director

2021-06-10 17:34:40 -0400 2021-06-08 A 46,238 a 46,238 direct

LESCHLY MARK - Director

2021-06-10 17:42:35 -0400 2021-06-08 A 19,619 a 19,619 direct

GUYER SHELLY D - Director

2021-06-10 17:37:23 -0400 2021-06-08 A 19,619 a 19,619 direct

GOEDDEL DAVID V - Director - > 10% Owner

2021-06-10 17:41:12 -0400 2021-06-08 A 19,619 a 19,619 direct

HOOPER SUZANNE SAWOCHKA - Director

2021-06-10 17:36:14 -0400 2021-06-08 A 19,619 a 19,619 direct

CHEN JIN-LONG - Director - Officer CHIEF SCIENTIFIC OFFICER

2021-06-07 16:49:41 -0400 2021-06-03 M 69,444 $1.44 a 989,449 direct 2.3202 11.4849 26.1021 27.9002 23 0.0 1

CHEN JIN-LONG - Director - Officer CHIEF SCIENTIFIC OFFICER

2021-06-07 16:49:41 -0400 2021-06-03 M 69,444 d 0 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
NGM BIOPHARMACEUTICALS INC NGM 2021-07-23 22:15:03 UTC -1.1965 1.2765 200000
NGM BIOPHARMACEUTICALS INC NGM 2021-07-23 21:45:03 UTC -1.1965 1.2765 200000
NGM BIOPHARMACEUTICALS INC NGM 2021-07-23 21:15:03 UTC -1.1965 1.2765 200000
NGM BIOPHARMACEUTICALS INC NGM 2021-07-23 20:45:03 UTC -1.1965 1.2765 200000
NGM BIOPHARMACEUTICALS INC NGM 2021-07-23 20:15:05 UTC -1.1965 1.2765 200000
NGM BIOPHARMACEUTICALS INC NGM 2021-07-23 19:45:03 UTC -1.1965 1.2765 200000
NGM BIOPHARMACEUTICALS INC NGM 2021-07-23 19:15:03 UTC -1.1965 1.2765 200000
NGM BIOPHARMACEUTICALS INC NGM 2021-07-23 18:45:03 UTC -1.1965 1.2765 200000
NGM BIOPHARMACEUTICALS INC NGM 2021-07-23 18:15:03 UTC -1.1965 1.2765 200000
NGM BIOPHARMACEUTICALS INC NGM 2021-07-23 17:45:03 UTC -1.1965 1.2765 200000
NGM BIOPHARMACEUTICALS INC NGM 2021-07-23 17:15:02 UTC -1.1965 1.2765 200000
NGM BIOPHARMACEUTICALS INC NGM 2021-07-23 16:45:02 UTC -1.1965 1.2765 200000
NGM BIOPHARMACEUTICALS INC NGM 2021-07-23 16:15:03 UTC -1.1965 1.2765 200000
NGM BIOPHARMACEUTICALS INC NGM 2021-07-23 15:45:02 UTC -1.1965 1.2765 200000
NGM BIOPHARMACEUTICALS INC NGM 2021-07-23 15:15:03 UTC -1.1965 1.2765 200000
NGM BIOPHARMACEUTICALS INC NGM 2021-07-23 14:45:03 UTC -1.1965 1.2765 200000
NGM BIOPHARMACEUTICALS INC NGM 2021-07-23 14:15:03 UTC -1.1965 1.2765 200000
NGM BIOPHARMACEUTICALS INC NGM 2021-07-23 13:45:03 UTC -1.1965 1.2765 200000
NGM BIOPHARMACEUTICALS INC NGM 2021-07-23 13:15:03 UTC -1.1965 1.2765 200000
NGM BIOPHARMACEUTICALS INC NGM 2021-07-23 12:45:03 UTC -1.1965 1.2765 200000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund NGM -32.0 shares, $-394.56 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund NGM -20.0 shares, $-246.6 2020-03-31 N-PORT

Elevate your investments